Summary: Two House lawmakers have joined to form a bipartisan caucus to advocate for research into the therapeutic potential of psychedelic drugs. Originally appearing here (Archived)
Originally appearing here (Archived)
Originally appearing here (Archived)
Originally appearing here (Archived)
Originally appearing here (Archived)
Originally appearing here (Archived)
Originally appearing here (Archived)
Summary: “2023 could potentially be a landmark year for us. This could be the first psychedelic-assisted therapy approved by a regulatory body,” says Amy Emerson, CEO of MAPS Public Benefit …
Originally appearing here (Archived)
Originally appearing here (Archived)
Originally appearing here (Archived)
